GlobalGov › Germany › Solicitation

Germany – Dressings – Abschluss nicht-exklusiver Liefervereinbarungen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 05, 2026
Response Due
Active
Status

Opportunity Overview

Germany – Dressings – Conclusion of non-exclusive supply agreements with the possibility of concluding agreements at any time within the framework of the so-called Open House procedure.

This is one of 1,752 active Germany Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryHealth Services
PublishedSeptember 23, 2024
Procurement stageActive solicitation
Response dueOctober 05, 2026
StatusOpen — accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Sevelamer hydrochlorid (ATC-Code V03AE02).
Open-label pharmaceutical discount agreements: risankizumab, ATC L04AC18
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Relugolix ATC L02BX04
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Pazopanib
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Fluticasonfuroat, ATC R03AK10
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Vilanterol/Fluticason (ATC-Code nach WHO: R03AK10)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 (OBG) für die Zeit 01.11.2024 - 31.10.2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Cinnarizin und Dimenhydrinat, ATC N07CA22

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.